x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

IMATINIB TEVA

Imatinib mesilate   
    • Marketing authorisation without orphan designation  - Europe

    • Diseases list
      • Chronic myeloid leukemia
      • Acute lymphoblastic leukemia
      • Chronic eosinophilic leukemia
      • Dermatofibrosarcoma protuberans
      • Primary hypereosinophilic syndrome
      • Idiopathic hypereosinophilic syndrome
      • Myelodysplastic/myeloproliferative disease
    • Detailed information

Additional information

Research on this medical product

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.